Skip to content
DataLookout
Menu

NCT07371000

Early Detection of OAB and Elimination of Negative Impact on Quality of Life

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Final enrollment: 17 participants, 2% of the 1000 planned
    • Eligibility criteria expanded, about 5 words
    • Trial completed
    • Site details revised at 20 of 20 sites
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Pilot testing with 1,000 participants
Timeframe: From enrollment to the end of examination in 3 months
Number of participants (completion of anonymous screening test)
Timeframe: from enrollment up to 1 week
Percentage of people with suspected OAB who agreed to participate in a follow-up examination with specialist
Timeframe: From enrollment up to 3 months
Percentage of people with a specialist confirmed diagnosis of OAB at the face-to-face visit
Timeframe: Through study completion, an average of 6 months
Percentage of people who attended follow-up examination after 3 months
Timeframe: Through study completion, an average of 9 months

Arms and interventions

OAB Screening ArmOther

Participants matching all the inclusion \& exclusion criteria will undergo a standardized screening process for the diagnosis of OAB. This process involves the use of an online screening self-testing tool, where the data from individual questionnaires specific to OAB diagnosis will be evaluated by a specialist.

Other: Standardized Screening Protocol

Sites

20 sites in 1 country